3-((4-(Piperidin-4-yl)phenyl)amino)piperidine-2,6-dione hydrochloride

Catalog No. :
ACWGVC379
CAS No. :
2259851-38-0
Molecular Formula :
C16H22ClN3O2
Molecular Weight :
323.82

IUPAC Name:3-((4-(piperidin-4-yl)phenyl)amino)piperidine-2,6-dione hydrochloride

3-((4-(Piperidin-4-yl)phenyl)amino)piperidine-2,6-dione hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$59.00Login to see priceIn stockIn stock
250mg98%$98.00Login to see priceIn stockIn stock
1g98%$325.00Login to see priceIn stockInquiry
5g98%$1530.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-((4-(Piperidin-4-yl)phenyl)amino)piperidine-2,6-dione hydrochloride
IUPAC Name3-((4-(piperidin-4-yl)phenyl)amino)piperidine-2,6-dione hydrochloride
Molecular FormulaC16H22ClN3O2
Molecular Weight323.82
SMILESO=C(C(NC1=CC=C(C2CCNCC2)C=C1)CC3)NC3=O.[H]Cl
InChI KeySUJCEDQQDYQAND-UHFFFAOYSA-N
Synonym3-((4-(Piperidin-4-yl)phenyl)amino)piperidine-2,6-dione hydrochloride;3-((4-(Piperidin-4-yl)phenyl)amino)piperidine-2,6-dione hydr;3-[4-(Piperidin-4-yl)phenylamino]piperidine-2,6-dione HCl
CAS No.2259851-38-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWGVC379 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWGVC379 route product structure diagram
    ACWGVC3792259851-38-0 In Stock
Inquiry

2. ACWGVC379 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWGVC379 route product structure diagram
    ACWGVC3792259851-38-0 In Stock
Inquiry

Comments (0)